TESARO sincerely thanks the many women who participated in our NOVA clinical research trial.
See the March 27, 2017 press release: http://files.shareholder.com/downloads/AMDA-Z6KN1/3700491149x0x934849/52B39B23-4A61-475B-955F-2F9C99645F81/Zejula_FDA_approval_news_release_032417.pdf
Battling ovarian cancer can be challenging both physically and emotionally. Participating in a clinical trial can provide a sense of hope.
TESARO is sponsoring two clinical research trials in ovarian cancer that are described here. These trials are being done to find out if niraparib, a drug called a PARP inhibitor, is safe and effective at different points in the treatment of ovarian cancer patients. Learn more about whether you might be eligible for one of the trials here.
When you participate in a clinical trial, you help to advance research that explores more effective treatments for individuals just like you and families that are affected by ovarian cancer.
Joining together as partners we can fight against ovarian cancer.